EQT

FlixBus, operated by FlixMobility, is a notable provider of intercity travel, focusing on affordable, convenient, and environmentally-friendly transportation solutions. Since its inception in 2013, the company has established Europe's largest long-distance bus network and introduced green long-distance trains in 2018, alongside a pilot for all-electric buses in Germany and France. The platform offers travelers a sustainable alternative to private transportation, featuring amenities such as free WiFi, flexible online booking, and innovative ticketing systems. FlixBus also expanded its services to the United States in 2018, bringing its unique travel model to a broader audience. By collaborating with regional bus partners and private train companies, FlixMobility combines technological innovation with traditional transportation expertise, positioning itself as a leader in the evolving mobility landscape. As a result, FlixBus has transformed the travel experience for over 100 million people across Europe and the United States while contributing to job creation in the mobility sector.

Vico Therapeutics B.V., founded in 2019 and based in Leiden, the Netherlands, specializes in developing RNA modulating therapies aimed at treating rare neurological disorders. The company's primary focus is on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome. By discovering and delivering innovative therapies, Vico Therapeutics aims to address the unmet medical needs of patients suffering from these severe central nervous system disorders, thereby enhancing treatment options available to medical professionals.

Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, focused on developing point-of-care diagnostic solutions for infectious diseases. Established in 2005, the company offers the binx io system, a FDA-cleared and CLIA-waived platform that detects sexually transmitted infections, including chlamydia and gonorrhea, delivering results comparable to central lab performance within approximately thirty minutes. Additionally, Binx Health provides the Callisto system, which meets various throughput requirements for testing in decentralized and near-patient settings. The company's innovative approach aims to enhance access to healthcare by overcoming traditional barriers and improving patient experiences through rapid polymerase chain reaction (PCR)-based testing and a comprehensive digital program that includes counseling and follow-up care. Binx Health has also formed a strategic partnership with Sherlock Biosciences to further advance its capabilities in diagnostics.

Tubulis GmbH, founded in 2019 and based in Munich, Germany, specializes in the research, design, and development of protein-drug conjugates, particularly transformative antibody-drug conjugates (ADCs). The company focuses on creating innovative chemotherapeutic medications that are specifically tailored to combat cancer and chronic disorders. By integrating proprietary technologies with disease-specific biology, Tubulis aims to identify novel protein-drug combinations that enable clinicians to treat cancer patients while minimizing the risks and side effects typically associated with traditional chemotherapy.

Phagenesis is developing a device for the treatment for dysphagia, the inability to swallow safely, that often accompanies stroke or other neuro-deficit diseases. The approach is to harness the brain's own capacity for relearning functions that have been lost through brain damage (via "neuroplasticity" or "cortical remapping"). Focusing initially on the care of stroke patients as they recover in hospital (acute care), Prof Shaheen Hamdy of the University of Manchester, UK, painstakingly devised a method of delivering electrical signals from the pharynx (throat) along nerve cells directly to the relevant parts of the brain. The results of his work have been published in top peer-reviewed scientific and medical journals, including The Lancet, the Nature group of publications, and Gastroenterology.

InstaVolt is leading the way in EV charging infrastructure, helping to make the UK an easier place to own and operate an electric vehicle. They own, install and maintain rapid electric vehicle charging units all over the country, giving landowners the opportunity to earn a rental income by housing them, and giving EV drivers access to the fastest charging available. They are driven by their passion for protecting the environment. At their core is a mission to improve air quality and reduce carbon emissions. Air quality has reached critical levels in cities across the UK and cars, buses and lorries have been proven as contributing significantly to the problem. Increasing the use of electric vehicles, which emit zero emissions, is an important part of the solution. According to Government statistics, one of the biggest barriers that deters people from buying EVs is range anxiety – the fear of running out of charge. InstaVolt will ensure a rapid charging point is easily accessible to everyone in the country. They believe that charging an electric vehicle should be quick and easy. It’s why, unlike many other companies, they operate an ‘open charger’ model, so anyone can use their charging points on a pay-as-you-go basis. No monthly subscription and no membership cards are required.

Vico Therapeutics B.V., founded in 2019 and based in Leiden, the Netherlands, specializes in developing RNA modulating therapies aimed at treating rare neurological disorders. The company's primary focus is on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome. By discovering and delivering innovative therapies, Vico Therapeutics aims to address the unmet medical needs of patients suffering from these severe central nervous system disorders, thereby enhancing treatment options available to medical professionals.

AgomAb Therapeutics N.V., based in Gent, Belgium, focuses on developing innovative therapies using anti-MET antibodies for treating various diseases. The company specializes in creating agonistic monoclonal antibodies, known as agomAbs, which aim to stimulate molecular and cellular repair mechanisms to regenerate damaged tissues. This approach has the potential to restore organ function in patients suffering from fibrotic, inflammatory, autoimmune, and degenerative conditions. AgomAb is committed to exploring biologically validated pathways, particularly Transforming Growth Factor β and Hepatocyte Growth Factor, and is equipped with expertise in organ-specific small molecules and high-affinity antibodies. With a diversified clinical pipeline targeting multiple fibrotic conditions and comprehensive research and development capabilities, AgomAb Therapeutics is well-positioned in the therapeutic landscape.

Xeltis is a clinical-stage medical device company focused on transforming cardiovascular treatment through innovative restorative technologies. The company has developed advanced polymer-based devices, including bioabsorbable heart valves and implantable small diameter blood vessels, intended for hemodialysis vascular access and coronary artery bypass graft surgery. These devices leverage proprietary technology to facilitate endogenous tissue restoration, allowing the body to naturally regenerate the complex structures being replaced. Xeltis emerged from the merger of two university spin-offs from the Netherlands and Switzerland and operates in both the Netherlands and the USA. The company is backed by several venture capital firms and has secured significant funding from the European Investment Bank and the European Innovation Council Accelerator. Currently, Xeltis is conducting ongoing clinical trials to advance its restorative cardiovascular solutions.

IntegrityNext is a company based in Munich, Bayern, focused on providing a cloud-based platform for monitoring supplier sustainability and compliance. Established in April 2016 by Martin Berr-Sorokin, the platform allows businesses to automatically gather necessary supplier self-assessments and certifications while also monitoring social media for potential malpractice and reputational risks. Through its features, which include automated self-assessments, risk alerts, and a pre-built supplier questionnaire, IntegrityNext helps small and medium-sized enterprises navigate compliance data requirements set by international regulators. The platform's real-time dashboard and assessment framework enable companies to effectively manage compliance risks and streamline their processes.

Xeltis is a clinical-stage medical device company focused on transforming cardiovascular treatment through innovative restorative technologies. The company has developed advanced polymer-based devices, including bioabsorbable heart valves and implantable small diameter blood vessels, intended for hemodialysis vascular access and coronary artery bypass graft surgery. These devices leverage proprietary technology to facilitate endogenous tissue restoration, allowing the body to naturally regenerate the complex structures being replaced. Xeltis emerged from the merger of two university spin-offs from the Netherlands and Switzerland and operates in both the Netherlands and the USA. The company is backed by several venture capital firms and has secured significant funding from the European Investment Bank and the European Innovation Council Accelerator. Currently, Xeltis is conducting ongoing clinical trials to advance its restorative cardiovascular solutions.

va-Q-tec is a high-tech company established in 2001, specializing in innovative insulation solutions, particularly through vacuum insulation panels (VIPs). The company's products are designed to enhance energy efficiency and are environmentally friendly, making them suitable for various applications. va-Q-tec's technology significantly reduces energy costs in diverse sectors, including the transportation of pharmaceutical products, refrigeration and freezing appliances, construction, and automotive and aerospace industries. The company operates through several segments, with a strong presence in Germany and across the European Union. Its customer base spans multiple industries, including healthcare, logistics, appliances and food, construction, and technical sectors.

Founded in 1933, the Saur Group is the third largest player in the French water distribution and waste water management market. In addition to its core activity, the company has also developed into municipal waste collection and treatment, and also certain ancillary services to local authorities.

SHL Medical AG is a Swiss company based in Zug that specializes in designing, developing, and manufacturing advanced drug delivery systems, including auto-injectors, pen injectors, and inhaler systems. Founded in 1989, the company serves pharmaceutical and biotechnology companies worldwide by providing comprehensive services that include final assembly, labeling, and packaging. In addition to its core focus on drug delivery systems, SHL Medical also offers contract manufacturing services and produces various medical products such as pressure mattress systems and patient lifting slings. The company is committed to maintaining high-quality standards and adhering to strict regulatory requirements, ensuring it delivers innovative solutions tailored to the needs of its clients.

eTheRNA immunotherapies NV specializes in the development of mRNA-based immunotherapies that harness the key role of dendritic cells in the immune system. The company focuses on treating melanoma, triple-negative breast cancer, and infectious diseases through its innovative TriMix technology, which enhances the immune response. Founded in 2013 and headquartered in Niel, Belgium, eTheRNA collaborates strategically with China Grand Pharmaceutical and Healthcare Holdings Limited to advance its research and development efforts. The company aims to lead in nucleic acid-based medicine, enabling partners to create new therapeutic options and improve patient outcomes.

FundamentalVR have been working with leading pharmaceutical companies to combine virtual and mixed reality with haptic feedback using their ‘FeelRealVR’ platform to create simulated surgical procedures to help educate and train healthcare professionals. The company works at the nexus of haptics, machine learning, and immersive technologies (XR). FundamentalVR was established in 2012 by Chris Scattergood in London, England.

Envirotainer AB specializes in the production, development, and rental of active temperature-controlled containers designed for the air transportation of temperature-sensitive healthcare products. Established in 1986 and headquartered in Upplands Väsby, Sweden, the company operates internationally with facilities in major locations such as Singapore, Dallas, Frankfurt, and Toronto, along with a network station in Hyderabad. Envirotainer serves a diverse clientele, including pharmaceutical and biotech companies, by offering a comprehensive suite of services that encompasses laboratory testing, qualification, validation support, and training through the Qualified Envirotainer Program. With over 30 years of experience, Envirotainer has established itself as a leader in secure cold chain solutions, ensuring that pharmaceutical products are transported in a controlled environment to meet the demands of the global market.

InstaVolt is leading the way in EV charging infrastructure, helping to make the UK an easier place to own and operate an electric vehicle. They own, install and maintain rapid electric vehicle charging units all over the country, giving landowners the opportunity to earn a rental income by housing them, and giving EV drivers access to the fastest charging available. They are driven by their passion for protecting the environment. At their core is a mission to improve air quality and reduce carbon emissions. Air quality has reached critical levels in cities across the UK and cars, buses and lorries have been proven as contributing significantly to the problem. Increasing the use of electric vehicles, which emit zero emissions, is an important part of the solution. According to Government statistics, one of the biggest barriers that deters people from buying EVs is range anxiety – the fear of running out of charge. InstaVolt will ensure a rapid charging point is easily accessible to everyone in the country. They believe that charging an electric vehicle should be quick and easy. It’s why, unlike many other companies, they operate an ‘open charger’ model, so anyone can use their charging points on a pay-as-you-go basis. No monthly subscription and no membership cards are required.

Perfuze is a neurovascular medical device company based in Galway, Ireland, established in 2018. The company specializes in developing innovative catheter technology aimed at treating acute ischemic stroke. By utilizing its proprietary catheter-based aspiration platform, Perfuze focuses on optimizing the efficiency of clot removal, which in turn seeks to enhance clinical outcomes and reduce procedural times. This technology aims to simplify the treatment process while minimizing the need for alternative interventions, providing patients with a cost-effective solution for ischemic stroke therapy.

ViCentra, they like to keep things simple. ViCentra believe that if products are simple, look beautiful and deliver superb results, they’ll be more enjoyable to use and more likely to help people achieve great things. Creating brilliant products doesn’t end at the manufacturing line though – they also believe in the power of great customer experiences. From our offices in the Netherlands and UK, they’re creating healthcare products with this philosophy firmly in mind. They don’t design for patients – they design for people.

AviadoBio is focused on developing innovative gene therapies aimed at transforming the lives of individuals affected by neurodegenerative disorders, specifically frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company leverages advanced research from King's College London and the UK Dementia Research Institute to create its therapeutic platform. By integrating a comprehensive understanding of brain biology with proprietary gene therapy techniques, AviadoBio seeks to address the challenges of effectively delivering treatments to targeted areas in the brain. This approach aims to enhance the therapeutic potential of gene therapies, offering hope for halting or potentially reversing the progression of these debilitating diseases.

EQT Partners AB is a private equity and venture capital firm based in Stockholm, Sweden, with a global presence through additional offices in major cities across Europe, Asia, and North America. Founded in 1994, EQT specializes in a wide array of investment strategies, including expansion capital, buyouts, and growth equity, focusing on medium to large-sized companies with consistent cash flows or significant intrinsic value. The firm targets various sectors, such as healthcare, technology, energy, and infrastructure, and emphasizes investments in mid-market situations, over-leveraged companies, and distressed assets. EQT's investment approach is characterized by taking controlling or co-controlling equity stakes in its portfolio companies and actively participating in their management, often securing board seats. The firm typically holds investments for four to eight years, aiming to enhance growth and create long-term value for stakeholders.

Egle Therapeutics SAS is a biotechnology company based in Paris, France, founded in 2020. It specializes in developing innovative immunotherapies that target immune suppressor regulatory T-cells (Tregs) for the treatment of oncology and autoimmune diseases. The company's research focuses on a proprietary drug pipeline that includes computationally designed IL-2 variants aimed at modulating Treg activity. This approach seeks to either engage or dis-engage Tregs, facilitating the development of therapies that can effectively combat cancer and other related conditions by addressing the immune suppression caused by Tregs. Egle Therapeutics aims to advance its unique portfolio to provide new treatment options in the healthcare field.

They are the largest independent MGA in the UK. They provide their insurance products exclusively through authorised insurance brokers in over 60 countries around the world. Wholesale or retail, big or small, generalist or specialist, all of their brokers have access to underwriters who can make fast decisions and provide flexible solutions. By providing market-leading products, great service and configurable online systems, they help their brokers carry out business more easily, efficiently and profitably. That’s probably why they’ve won eight major industry awards in the last year and over 1,500 businesses move their insurance to CFC every month.

Formo is a pioneering cellular agriculture company based in Europe that specializes in creating animal-free dairy products. By utilizing precision fermentation, Formo develops real, nature-identical milk proteins, allowing for the production of clean dairy alternatives. The company aims to provide sustainable and healthy options for consumers, particularly those seeking vegan food products. Through innovative biotechnology, Formo transforms nutrients into dairy proteins, contributing to a more equitable and environmentally friendly approach to dairy consumption.

Cardior Pharmaceuticals GmbH is a biotechnology company based in Hanover, Germany, established in 2016. The company specializes in the development of non-coding RNA-based therapeutics aimed at treating and preventing heart disease, a leading cause of mortality in the western world. Its primary focus is on CDR-132X, an oligonucleotide-based inhibitor that targets a molecular master switch (microRNA) responsible for pathological changes in the heart resulting from stress or injury. By advancing innovative therapies, Cardior Pharmaceuticals aims to address significant health challenges associated with cardiovascular conditions.

Mollie is a payments platform based in Amsterdam, founded in 2004, that simplifies the integration of payment solutions for online businesses. Serving over 50,000 clients, the company supports a variety of local payment methods, including Mastercard, VISA, PayPal, and iDEAL, among others. Mollie's technology-driven approach allows merchants to easily implement payment systems through a simple yet powerful API, facilitating one-click payments, fraud monitoring, and real-time accounting. By streamlining the payment process, Mollie enables businesses to efficiently manage their finances and enhance revenue generation while minimizing operational complexities.

Solarpack is an independent solar photovoltaic power producer that specializes in the development and operation of large-scale solar projects. Established in 2005 and headquartered in Getxo, Vizcaya, Spain, the company offers a comprehensive range of services, including financing, construction, and management of utility-scale solar plants. With a total operational capacity of 160 MW across 13 plants and asset management services for an additional 302 MW, Solarpack has a diversified geographical presence, employing over 140 people in 10 countries. The company aims to contribute to sustainable energy infrastructure while fostering social development within the communities it serves by creating economic value and promoting quality employment through its initiatives.

Parcel2Go is a leading online parcel delivery service based in the UK, offering a comprehensive range of courier services for both home and business users. The company operates a parcel delivery comparison platform that provides customers with an alternative to traditional postal services. By partnering with major courier companies such as FedEx, UPS, and Hermes, Parcel2Go enables users to send packages of various sizes to destinations domestically and internationally. The platform allows customers to manage their orders online and track their shipments, ensuring a convenient and cost-effective delivery experience.

Anticimex is a global specialist in preventive pest control with operations in 17 counties across Europe, Asia-Pacific and the US with headquarters in Stockholm, Sweden. With its approximately 4,500 employees, Anticimex serves more than 3 million customers across the globe and offers a broad range of preventive pest control solutions, including the digital solution Anticimex SMART and pest insurance.

Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, focused on developing point-of-care diagnostic solutions for infectious diseases. Established in 2005, the company offers the binx io system, a FDA-cleared and CLIA-waived platform that detects sexually transmitted infections, including chlamydia and gonorrhea, delivering results comparable to central lab performance within approximately thirty minutes. Additionally, Binx Health provides the Callisto system, which meets various throughput requirements for testing in decentralized and near-patient settings. The company's innovative approach aims to enhance access to healthcare by overcoming traditional barriers and improving patient experiences through rapid polymerase chain reaction (PCR)-based testing and a comprehensive digital program that includes counseling and follow-up care. Binx Health has also formed a strategic partnership with Sherlock Biosciences to further advance its capabilities in diagnostics.

Epidemic Sound is a Swedish music company that produces and licenses music for video creators and businesses globally. Founded in 2009 and headquartered in Stockholm, the company offers a vast catalogue of over 30,000 tracks across more than 180 genres, including acoustic, classical, and electronic music, as well as various moods and themes. Epidemic Sound operates on a subscription-based model, allowing users unlimited access to its music library or the option to license individual tracks. All music usage comes with worldwide clearance for all platforms and for an unlimited duration, eliminating legal risks for users. This model is tailored for storytellers, broadcasters, production companies, and content creators, including YouTubers, enabling them to enhance their audiovisual projects effortlessly. The company also provides online services that facilitate playlist creation and music updates, making it an essential resource for modern digital media production.

IVC Evidensia is a prominent provider of veterinary services, operating a vast network of over 2,600 hospitals and clinics across Europe. Founded in 2011, the company employs more than 41,000 veterinarians, nurses, referral specialists, and other staff dedicated to animal care. IVC Evidensia emphasizes a decentralized approach that encourages innovation and clinical flexibility while also offering integrated support services, such as purchasing assistance and veterinary consultancy. The company is committed to guiding pet owners on balanced nutrition tailored to the specific needs of their animals, regardless of breed, age, or gender.

Molslinjen is a privately held company that provides ferry services between Jutland and the island of Zealand in Denmark. The company operates a fleet of catamaran ferries designed for efficient marine transportation, allowing for easy boarding and disembarking of passengers, cars, trucks, and buses. This service aims to offer fast and comfortable travel options, supporting both domestic transportation needs and enhancing connectivity between regions.

Casa.it S.r.l. is an online property portal based in Milan, Italy, that has been operational since 1996. The company specializes in providing advertising services for real estate, offering a comprehensive platform for users to access information on real estate agencies, as well as properties available for sale or rent. This includes a diverse range of listings such as flats, villas, independent houses, penthouses, and lofts. Casa.it serves as a vital resource for individuals seeking residential options, facilitating connections between property seekers and real estate professionals in Italy.

Idealista operates an online property portal that serves agents and private individuals in Spain, Italy, and Portugal. The platform functions as a digital real estate marketplace, providing buyers and sellers with essential real-time information to facilitate property transactions. By offering a user-friendly interface, Idealista helps alleviate the challenges associated with finding a home, thus supporting millions of users in their real estate endeavors. Additionally, the company allows property owners to advertise their listings through a subscription model, enabling them to reach a broader audience while accessing valuable market insights.

Colisée is a key player in the global health care and old-age dependency sector, and has developed a real expertise in elderly people care and well-being. Its network includes 90 facilities in France, Italy and Spain and close to 70 home-based services agencies in France. In those two business segments, Colisée employs more than 6,700 people.

Depict.ai, founded in 2019 and based in Stockholm, Sweden, develops a product recommendation engine aimed at enhancing e-commerce stores' capabilities. The software is designed to provide high-quality product recommendations comparable to those of major retailers, enabling smaller businesses to enhance their digital storefronts and compete effectively in the market. By democratizing access to advanced recommendation technology, Depict.ai allows clients to increase their overall revenue without the need for extensive sales data. This empowers brands to present their unique stories and identities more effectively, ultimately supporting their growth in a competitive landscape.

Vico Therapeutics B.V., founded in 2019 and based in Leiden, the Netherlands, specializes in developing RNA modulating therapies aimed at treating rare neurological disorders. The company's primary focus is on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome. By discovering and delivering innovative therapies, Vico Therapeutics aims to address the unmet medical needs of patients suffering from these severe central nervous system disorders, thereby enhancing treatment options available to medical professionals.

ViCentra, they like to keep things simple. ViCentra believe that if products are simple, look beautiful and deliver superb results, they’ll be more enjoyable to use and more likely to help people achieve great things. Creating brilliant products doesn’t end at the manufacturing line though – they also believe in the power of great customer experiences. From our offices in the Netherlands and UK, they’re creating healthcare products with this philosophy firmly in mind. They don’t design for patients – they design for people.

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. Cybin’s goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug discovery platforms, innovative drug delivery systems, and novel formulation approaches and treatment regimens. The Company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder, and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder, and has a research pipeline of investigational psychedelic-based compounds. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands, and Ireland. For company updates and to learn more about Cybin, visit www.cybin.com or follow the team on Twitter, LinkedIn, YouTube, and Instagram.

Freepik is a digital platform based in Málaga, Spain, specializing in providing designers and creative professionals with access to a vast library of graphic resources. Established in 2010, Freepik has evolved into a comprehensive content creation tool, integrating advanced generative AI technology to streamline the production of high-quality audiovisual content. The platform caters to a diverse user base, including designers, photographers, architects, and advertisers, offering various assets such as illustrations, photos, icons, and presentation templates. With over 100 million users and nearly 800,000 subscribers, Freepik combines its extensive stock content library with AI-driven tools that simplify and enhance the creative process. By continuously innovating and adapting to new design trends, Freepik redefines the landscape of digital creativity, making it easier for users to generate, refine, and optimize visuals efficiently.

Kiadis Pharma N.V. is a biopharmaceutical company based in Amsterdam, the Netherlands, specializing in cell-based immunotherapy products aimed at treating blood cancers and inherited blood disorders. The company is currently advancing K-NK002, which is undergoing Phase II clinical trials for blood cancer patients receiving haploidentical hematopoietic stem cell transplants with the post-transplant cyclophosphamide protocol. Additionally, Kiadis Pharma is developing K-NK003, currently in Phase I/II trials for patients with acute myeloid leukemia relapse or refractory cases. The preclinical product pipeline includes K-NK00X, a natural killer (NK) cell therapy candidate targeting various solid tumors. Kiadis Pharma also collaborates with several institutions, including Harbour BioMed and Erasmus Medical Center, to explore a combination of monoclonal antibodies and natural killer cells as a potential treatment for COVID-19. Founded in 1997, Kiadis Pharma is committed to addressing significant unmet medical needs in the treatment of blood-related conditions.

FoRx Therapeutics AG is a biotechnology company based in Basel, Switzerland, founded in 2019. The company specializes in the development of innovative therapeutics for cancer treatment, specifically targeting key molecular pathways involved in DNA replication stress. By focusing on these novel pathways, FoRx Therapeutics aims to create first-in-class compounds that offer a new approach to targeted anticancer therapies. Through its research and development efforts, the company seeks to provide effective solutions in the fight against cancer.

Deutsche Glasfaser Holding GmbH, founded in 2012 and based in Borken, Germany, specializes in the planning, construction, and operation of fiber optic networks, particularly targeting rural and suburban areas. As a significant player in the broadband telecommunications sector, the company aims to facilitate nationwide fiber optic expansion, contributing to Germany's digital advancement. Deutsche Glasfaser focuses on delivering fast and cost-effective fiber-to-the-home (FTTH) connections in collaboration with municipalities, positioning itself as a leader in innovative planning and construction processes. With substantial backing from experienced investors, the company has established a strong financial foundation, making it one of the most robust providers in the German market.

SHL Medical AG is a Swiss company based in Zug that specializes in designing, developing, and manufacturing advanced drug delivery systems, including auto-injectors, pen injectors, and inhaler systems. Founded in 1989, the company serves pharmaceutical and biotechnology companies worldwide by providing comprehensive services that include final assembly, labeling, and packaging. In addition to its core focus on drug delivery systems, SHL Medical also offers contract manufacturing services and produces various medical products such as pressure mattress systems and patient lifting slings. The company is committed to maintaining high-quality standards and adhering to strict regulatory requirements, ensuring it delivers innovative solutions tailored to the needs of its clients.

Recover Nordic Norge is the largest emergency response and damage control business in the Nordic region.

AM Pharma B.V. is a biopharmaceutical company based in Bunnik, the Netherlands, focused on developing and commercializing novel therapeutics for inflammatory and infectious diseases. Established in 2000, the company specializes in pre-clinical and clinical development using endogenous proteins and peptides derived from the human body. Its key products include alkaline phosphatase, aimed at treating acute kidney injury and ulcerative colitis, and the immune response amplifying peptide hLF1-11, which targets drug-resistant hospital-acquired infections. AM Pharma is committed to providing innovative therapies that enhance patient quality of life by addressing critical medical needs.

Epidemic Sound is a Swedish music company that produces and licenses music for video creators and businesses globally. Founded in 2009 and headquartered in Stockholm, the company offers a vast catalogue of over 30,000 tracks across more than 180 genres, including acoustic, classical, and electronic music, as well as various moods and themes. Epidemic Sound operates on a subscription-based model, allowing users unlimited access to its music library or the option to license individual tracks. All music usage comes with worldwide clearance for all platforms and for an unlimited duration, eliminating legal risks for users. This model is tailored for storytellers, broadcasters, production companies, and content creators, including YouTubers, enabling them to enhance their audiovisual projects effortlessly. The company also provides online services that facilitate playlist creation and music updates, making it an essential resource for modern digital media production.

Melita Limited is a telecommunications company based in Birkirkara, Malta, offering a range of converged services for both households and businesses. Founded in 1991, the company provides internet access, 4.5G mobile network services, high-definition digital television, and fixed telephony. Melita operates a nationwide network that includes hybrid fiber-coaxial cables and Wi-Fi mesh systems. Additionally, the company owns an undersea optical fiber cable and a Tier 3 data center for co-location services. It serves customers through retail outlets located in Valletta, Naxxar, Sliema, and Gozo, as well as a mobile repair center in Mosta. Melita was previously known as Melita Plc and is a former subsidiary of Melita BidCo Ltd.

Dellner Couplers AB, based in Falun, Sweden, specializes in manufacturing train connection systems and locomotive parts for the passenger rail industry. With over 75 years of experience, the company produces a range of products including couplers, gangways, hatches, dampers, and crash management systems. In addition to its core offerings, Dellner Couplers provides comprehensive after-sales services such as upgrades, modernization, overhaul, repairs, technical support, training, and maintenance. The company serves train builders and operators through a global network of subsidiaries, branches, and agents, ensuring safer and more reliable rail journeys for clients worldwide. Dellner Couplers operates as a subsidiary of Dellner Invest AB.

Snipr Biome ApS is a biotechnology company based in Copenhagen, Denmark, focusing on the development of CRISPR technology for the treatment of microbial diseases. Established in 2017, the company aims to revolutionize how such diseases are addressed by leveraging the adaptive immune system to create medicines that selectively target and eliminate harmful bacteria based on their specific DNA sequences. By utilizing a novel approach that subverts elements of the endogenous bacterial CRISPR machinery, Snipr Biome provides health professionals with innovative tools for targeted microbiome engineering, enhancing the precision and effectiveness of treatments for bacterial infections.

WS Audiology A/S was formed in 2019 through the partnership of Singapore-headquartered Sivantos and Lynge/Denmark-based Widex. Two pioneers joining forces with one clear ambition: to expand hearing care for the millions of people with hearing needs.

Founded in 1933, the Saur Group is the third largest player in the French water distribution and waste water management market. In addition to its core activity, the company has also developed into municipal waste collection and treatment, and also certain ancillary services to local authorities.

Finclude operates a credit scoring platform that facilitates the assessment of consumer creditworthiness across Europe. By utilizing a unique approach that focuses on transactional behavior, Finclude enables businesses to evaluate individuals regardless of their credit history. The platform aggregates and interprets data from various banks, providing a comprehensive view of a customer's affordability and creditworthiness. This innovative system supports more informed credit decisions for both businesses and consumers, promoting greater financial inclusivity.

Veritas Petroleum Services is a global provider of testing, inspection, and advisory services, operating five laboratories strategically located in the Netherlands, Singapore, Houston, Fujairah, and Manchester. The company specializes in fuel quality testing, bunker quantity surveys, oil condition monitoring, and transformer oil testing, among other services. By offering these solutions, Veritas Petroleum Services assists clients in the marine, power, and renewable sectors to optimize their operational performance. The company focuses on helping its customers improve fuel management, reduce fuel costs, enhance operational efficiency, and comply with environmental regulations.

HyTest Ltd. is a manufacturer of monoclonal antibodies and antigens, primarily serving the In Vitro Diagnostic (IVD) industry. Established in 1994 and located in Turku, Finland, the company specializes in developing products for various clinical areas, including cardiac markers, infectious diseases, and metabolic syndrome, as well as veterinary diagnostics. HyTest offers innovative solutions for assay development and research applications, providing a range of products such as antibodies, antigens, and biomarkers. By focusing on research and development, HyTest enables its clients to deliver accurate testing solutions across diverse healthcare sectors.

Artios Pharma Limited is a biotechnology company based in Cambridge, United Kingdom, that specializes in developing innovative cancer treatments targeting DNA damage response (DDR) pathways. Founded in 2015, the company is dedicated to creating first-in-class therapies aimed at selectively killing cancer cells. Artios's product pipeline features several promising programs, including a focus on DNA polymerase theta (Polθ), which plays a crucial role in DNA repair processes. Additionally, the company is advancing an in-licensed program that targets a newly identified protein linked to DDR and is developing a novel treatment aimed at DNA nucleases involved in these pathways. Artios collaborates with Cancer Research Technology and prominent DNA repair researchers globally to enhance its research and development efforts.

SUSE is a global leader in open source solutions, providing reliable and enterprise-grade software to a diverse range of industries, including automotive, telecom, banking, healthcare, manufacturing, retail, and technology. With a strong focus on Enterprise Linux, Kubernetes Management, and Edge solutions, SUSE supports mission-critical workloads for over 60% of the Fortune 500 companies. The company emphasizes collaboration with partners and communities to empower customers to innovate across various environments, from data centers to the cloud and edge. SUSE offers consulting, blended services, and training and certification, primarily generating revenue from subscriptions. Headquartered in Nuremberg, Germany, SUSE employs nearly 2,000 people globally and derives a significant portion of its revenue from North America.

Facile.it is an online price comparison platform based in Milan, Italy, that helps users compare prices and services across various sectors, including insurance, energy, telecommunications, loans, and banking. By leveraging technology, Facile.it enables clients to identify the best offers available in the market, allowing them to make informed decisions and achieve significant savings on their expenses. The platform is designed to streamline the comparison process, ultimately saving users time and effort as they seek to optimize their financial choices.

MediFox GmbH, founded in 1994 and headquartered in Hildesheim, Niedersachsen, Germany, specializes in developing software solutions for ambulatory nursing care service providers and nursing care homes. The company offers enterprise system software designed to support outpatient care services, inpatient facilities, and therapeutic practices. MediFox's software encompasses essential services such as resource and route planning, care and support documentation, management information systems, and administration services, including billing and factoring. By providing these tools, MediFox enables care providers to enhance their organizational structure and streamline their processes in response to evolving industry needs.

Dojo is a financial technology company specializing in card payment solutions for small and medium-sized businesses in the UK and Ireland. The company offers a range of services including contactless card machines, online payment systems, and integrated payment solutions, enabling over 100,000 businesses to accept payments in-store, online, over the phone, and on the go. Established in London, Dojo focuses on providing user-friendly and flexible payment options to enhance the transaction experience for both merchants and customers.

Broadnet is Norway's leading provider of fiber-based data communication to businesses, operators and public sector. Broadnet is owned by EQT- Northern Europe’s leading private equity company. Broadnet, as a national actor with its own nationwide fiber network, can guarantee maximum security and stability all the way to your business. Their network consists of 40.000 kilometres of fiber connecting more than 90 Norwegian towns from north to south. We have now started an unparalleled roll out of fiber which will provide an excellent cover for Norwegian companies.

Iver is a Swedish managed IT services provider with capabilities for full IT outsourcing, providing their clients with contracted services, including hosting, cloud and application management. Iver has managed to build strong customer relationships in Sweden and Norway by combining dedicated customer focus with high quality IT solutions.

Simplify Medical, Inc. is a medical device company that specializes in the design, development, manufacturing, and marketing of cervical and lumbar artificial discs for spinal use. Notably, it offers the Simplify Disc, a non-metallic cervical artificial disc that is MRI-compatible, allowing for comprehensive diagnostic imaging while eliminating the need for CT scans. This product addresses single-level symptomatic cervical disc disease and is aimed at skeletally mature patients requiring reconstruction following discectomy. Founded in 2013 and based in Sunnyvale, California, the company markets its products through distributors in various international markets, including the United Kingdom and Germany. Simplify Medical is committed to minimizing patient exposure to radiation and preserving the natural range of motion in the spine with its innovative artificial disc technology.

Candidator is an IT company based in Sweden that specializes in delivering comprehensive information technology operations, telephony, and outsourcing services to businesses and organizations in the Nordic market. Emphasizing the motto "Make IT simple," Candidator focuses on building long-term relationships with its clients by offering high-quality service and effective IT solutions. The company provides a range of services, including IT consulting, website development, and tailored business modules, all aimed at enhancing security and operational efficiency while reducing costs for its customers.

Studienkreis is one of Germany's largest providers of professional tutoring services, operating nearly 1,000 tuition schools nationwide since its establishment in 1974. The company specializes in providing offline and digital tutoring aimed at primary and secondary school students, offering support across all major subjects through its proprietary teaching materials and scientifically backed learning methodologies. Studienkreis focuses on helping children and adolescents enhance their academic performance and achieve consistently good grades. In addition to addressing specific academic queries, the company emphasizes fostering independent learning skills and a sense of responsibility in students, thereby improving their overall confidence in their educational journey.

Orphazyme is a Copenhagen-based biopharmaceutical company focused on developing innovative therapies for lysosomal storage diseases, which are serious genetic disorders. Founded on scientific discoveries from the academic work of Professor Marja Jäättela and Thomas Kirkegaard Jensen at the Danish Cancer Society, Orphazyme collaborates with leading academic institutions across Europe and the United States. The company is actively engaged in biopharmaceutical research and development, and it has entered into a strategic partnership with CombiGene AB to advance its objectives in this field.

Epidemic Sound is a Swedish music company that produces and licenses music for video creators and businesses globally. Founded in 2009 and headquartered in Stockholm, the company offers a vast catalogue of over 30,000 tracks across more than 180 genres, including acoustic, classical, and electronic music, as well as various moods and themes. Epidemic Sound operates on a subscription-based model, allowing users unlimited access to its music library or the option to license individual tracks. All music usage comes with worldwide clearance for all platforms and for an unlimited duration, eliminating legal risks for users. This model is tailored for storytellers, broadcasters, production companies, and content creators, including YouTubers, enabling them to enhance their audiovisual projects effortlessly. The company also provides online services that facilitate playlist creation and music updates, making it an essential resource for modern digital media production.

Caiway is a telecommunications infrastructure company based in the Netherlands, specializing in broadband services for over 350,000 households and businesses. The company has expanded its fiber network into remote areas, enhancing connectivity for municipalities and homes. As a regional internet service provider, Caiway offers a variety of services, including broadband, television, and telephony, delivered through its cable and fiber infrastructure. Major regions within Caiway's operational footprint include Westland, Schiedam, and Almelo, where it aims to provide reliable networking and high-quality service to its customers.

Xeltis is a clinical-stage medical device company focused on transforming cardiovascular treatment through innovative restorative technologies. The company has developed advanced polymer-based devices, including bioabsorbable heart valves and implantable small diameter blood vessels, intended for hemodialysis vascular access and coronary artery bypass graft surgery. These devices leverage proprietary technology to facilitate endogenous tissue restoration, allowing the body to naturally regenerate the complex structures being replaced. Xeltis emerged from the merger of two university spin-offs from the Netherlands and Switzerland and operates in both the Netherlands and the USA. The company is backed by several venture capital firms and has secured significant funding from the European Investment Bank and the European Innovation Council Accelerator. Currently, Xeltis is conducting ongoing clinical trials to advance its restorative cardiovascular solutions.

Two modern and strategically located office buildings in suburban Frankfurt.

BlueStep Bank is a specialist mortgage provider operating in the Nordic region, particularly in Sweden and Norway. Established in 2005, the bank has successfully served over 29,000 customers by addressing the needs of individuals who are often overlooked by traditional financial institutions. With a focus on understanding each customer's unique financial situation and future capabilities, BlueStep Bank offers a range of lending products alongside deposit services. The company employs approximately 200 individuals, emphasizing a personalized approach to mortgage financing that distinguishes it in the competitive banking landscape.

Simplify Medical, Inc. is a medical device company that specializes in the design, development, manufacturing, and marketing of cervical and lumbar artificial discs for spinal use. Notably, it offers the Simplify Disc, a non-metallic cervical artificial disc that is MRI-compatible, allowing for comprehensive diagnostic imaging while eliminating the need for CT scans. This product addresses single-level symptomatic cervical disc disease and is aimed at skeletally mature patients requiring reconstruction following discectomy. Founded in 2013 and based in Sunnyvale, California, the company markets its products through distributors in various international markets, including the United Kingdom and Germany. Simplify Medical is committed to minimizing patient exposure to radiation and preserving the natural range of motion in the spine with its innovative artificial disc technology.

Certara Inc. is a company specializing in biosimulation software and technology that enhances drug discovery, development, and regulatory processes. Founded in 2008 and headquartered in Princeton, New Jersey, Certara serves over 1,650 biopharmaceutical companies, academic institutions, and regulatory agencies worldwide. Its comprehensive platform integrates modeling and simulation, regulatory science, and market access solutions, enabling clients to streamline clinical trials, expedite regulatory approvals, and improve patient access to medicines. Certara's technology-enabled services encompass mechanistic and empirical biosimulation, drug development strategy, clinical pharmacology, regulatory writing, and market access. The company operates across multiple regions, including North America, Europe, and Asia Pacific, with a significant presence in various countries.

Cardior Pharmaceuticals GmbH is a biotechnology company based in Hanover, Germany, established in 2016. The company specializes in the development of non-coding RNA-based therapeutics aimed at treating and preventing heart disease, a leading cause of mortality in the western world. Its primary focus is on CDR-132X, an oligonucleotide-based inhibitor that targets a molecular master switch (microRNA) responsible for pathological changes in the heart resulting from stress or injury. By advancing innovative therapies, Cardior Pharmaceuticals aims to address significant health challenges associated with cardiovascular conditions.

Innovyze is a global provider of software solutions focused on wet infrastructure business analytics, catering to the technological needs of water and wastewater utilities, government agencies, and engineering organizations. The company serves a diverse clientele, including major cities and foremost utilities across the UK, Australia, East Asia, and North America, as well as top-rated design firms worldwide. With a strong presence in North America, Europe, and the Asia Pacific, Innovyze offers a connected portfolio of advanced products that empower engineers to effectively plan, manage, design, protect, operate, and sustain efficient and reliable water infrastructure systems. This comprehensive approach ensures that its clients can achieve optimal performance and enduring success in their operations.

Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, focused on developing point-of-care diagnostic solutions for infectious diseases. Established in 2005, the company offers the binx io system, a FDA-cleared and CLIA-waived platform that detects sexually transmitted infections, including chlamydia and gonorrhea, delivering results comparable to central lab performance within approximately thirty minutes. Additionally, Binx Health provides the Callisto system, which meets various throughput requirements for testing in decentralized and near-patient settings. The company's innovative approach aims to enhance access to healthcare by overcoming traditional barriers and improving patient experiences through rapid polymerase chain reaction (PCR)-based testing and a comprehensive digital program that includes counseling and follow-up care. Binx Health has also formed a strategic partnership with Sherlock Biosciences to further advance its capabilities in diagnostics.

Adamo is a telecom operator in Spain offering ultra high speed Internet via Fiber To The Home across Spain (Catalonia, Valencia, , Madrid, Andalucia...). We offer the highest speed in Spain, 1000 Mbit/s Internet access and our origin is Swedish. Coverage: Alicante, Almería, Asturias, Badajoz, Barcelona, Burgos, Cantabria, Castellón, Córdoba, Cuenca, Gerona, Granada, Guadalajara, Lérida, Lugo, Madrid, Navarra, Palencia, Sevilla, Tarragona, Toledo, Valencia, Valladolid & Vizcaya.

GlobalConnect is a prominent provider of fiber network, data center, and managed hosting services in Northern Europe, particularly Denmark and Germany. Founded in 1998 by Niels Zibrandtsen, the company operates an extensive optical fiber network spanning 12,500 kilometers and offers approximately 13,000 square meters of data center space. GlobalConnect delivers a range of services, including bandwidth connectivity, colocation, cloud infrastructure, and managed hosting, catering to both enterprises and consumers. With a workforce of over 200 employees, the company aims to enhance connectivity and support businesses in achieving efficient networking solutions.

IVC is the privately owned vet services platform in the UK with more than 290 sites and an online pet pharmacy. IVC employs approximately 2,700 FTEs, including 800+ FTE veterinarians.

Based in Vejle, Denmark, Fertin Pharma offers innovative, high-quality pharmaceutical and nutraceutical chewing gum products. Through partnerships with leading global pharma companies, we have consolidated our position as the preferred B2B partner for nicotine chewing gum. As a family-owned company with a unique heritage in chewing gum, we excel in every part of the development and manufacturing processes. We value an open, committed and professional relationship with our collaborators and when partnering with Fertin Pharma, you will experience a company dedicated to the field of medicated chewing gum.

AutoStore AS, founded in 1995 and headquartered in Nedre Vats, Norway, specializes in manufacturing automated warehousing and storage systems. The company offers innovative automated retrieval and material handling solutions designed to optimize space and efficiency in warehouses. Its patented system utilizes standardized bins stacked in a cubic configuration, enabling significant increases in storage capacity without expanding the physical footprint. AutoStore's products include a range of components such as robots, grids, bins, controllers, workstations, and warehouse management systems. The company collaborates with several strategic partners, including Bastian Solutions, AM Automation, Egemin, Swisslog, Element Logic, and LG CNS, to distribute its technology globally through a multi-distribution network.

OxThera AB is a biopharmaceutical company focused on developing treatments for primary and secondary hyperoxaluria, a condition that can lead to kidney stones and impaired kidney function. Founded in 2005 and based in Stockholm, Sweden, with an additional location in Knoxville, Tennessee, OxThera manufactures two main products: Oxabact and Oxazyme. Oxabact is an orally administered composition of live bacteria designed to enhance the removal of oxalate produced by the body, while Oxazyme is a non-systemic oral drug that contains recombinant oxalate decarboxylase, aimed at treating dietary hyperoxaluria and preventing kidney stones. The company holds worldwide patents for its innovative therapies and has received Orphan Drug designations for Oxabact in both Europe and the United States. Through its advanced biotherapy technologies, OxThera aims to improve kidney health and preserve organ function in patients affected by hyperoxaluria.

Dojo is a financial technology company specializing in card payment solutions for small and medium-sized businesses in the UK and Ireland. The company offers a range of services including contactless card machines, online payment systems, and integrated payment solutions, enabling over 100,000 businesses to accept payments in-store, online, over the phone, and on the go. Established in London, Dojo focuses on providing user-friendly and flexible payment options to enhance the transaction experience for both merchants and customers.

CHEP is a leading global provider of supply chain solutions, specializing in enhancing efficiency and sustainability for its customers. The company offers a range of services, including asset management and repair for unit load devices (ULDs), galley carts, and ground support equipment through its CHEP Aerospace Solutions division, headquartered in Zurich, Switzerland. This division manages the world's largest independent fleet of ULDs and operates a comprehensive global network for the maintenance and repair of containers, pallets, and inflight food service equipment. By providing tailor-made outsourcing solutions, CHEP enables airlines to focus on their core operations of transporting passengers and cargo while achieving significant cost savings and operational benefits. The company serves over 80 airlines worldwide, leveraging its unique capabilities and insights to help clients improve their logistics and supply chain management.

Vivasure Medical Limited is a medical device company based in Galway, Ireland, specializing in the research, development, and manufacture of arterial and venous closure devices utilizing its patented PerQseal technology. The company focuses on creating polymer implants and delivery systems aimed at minimally invasive vessel closures in the fields of cardiology, interventional radiology, and vascular surgery. Its primary product is a large-bore percutaneous closure device that employs an absorbable patch to effectively close large arteriotomies following transcatheter procedures, including transcatheter aortic valve replacement and endovascular aneurysm repair. Established in 2008, Vivasure Medical is dedicated to advancing medical solutions that enhance patient outcomes in vascular access procedures.

eTheRNA immunotherapies NV specializes in the development of mRNA-based immunotherapies that harness the key role of dendritic cells in the immune system. The company focuses on treating melanoma, triple-negative breast cancer, and infectious diseases through its innovative TriMix technology, which enhances the immune response. Founded in 2013 and headquartered in Niel, Belgium, eTheRNA collaborates strategically with China Grand Pharmaceutical and Healthcare Holdings Limited to advance its research and development efforts. The company aims to lead in nucleic acid-based medicine, enabling partners to create new therapeutic options and improve patient outcomes.

Kuoni Reisen Holding AG is a Switzerland-based company that serves the travel industry and government sectors through three primary business activities. It operates Global Travel Distribution (GTD), which supplies hotel accommodations and destination services to travel companies and agents. The company also offers Global Travel Services (GTS), which coordinates comprehensive destination management services, including accommodation, transportation, tours, and event management. Additionally, Kuoni provides Visa Facilitation Services (VFS) through numerous application centers worldwide, assisting with visa outsourcing. The company further enhances its portfolio with Kuoni Destination Management, specializing in event development, budgeting, and creative direction, as well as providing entertainment and AV technology solutions for various events. This diverse range of services underscores Kuoni's commitment to delivering innovative and comprehensive travel and event solutions.

ViCentra, they like to keep things simple. ViCentra believe that if products are simple, look beautiful and deliver superb results, they’ll be more enjoyable to use and more likely to help people achieve great things. Creating brilliant products doesn’t end at the manufacturing line though – they also believe in the power of great customer experiences. From our offices in the Netherlands and UK, they’re creating healthcare products with this philosophy firmly in mind. They don’t design for patients – they design for people.

Xeltis is a clinical-stage medical device company focused on transforming cardiovascular treatment through innovative restorative technologies. The company has developed advanced polymer-based devices, including bioabsorbable heart valves and implantable small diameter blood vessels, intended for hemodialysis vascular access and coronary artery bypass graft surgery. These devices leverage proprietary technology to facilitate endogenous tissue restoration, allowing the body to naturally regenerate the complex structures being replaced. Xeltis emerged from the merger of two university spin-offs from the Netherlands and Switzerland and operates in both the Netherlands and the USA. The company is backed by several venture capital firms and has secured significant funding from the European Investment Bank and the European Innovation Council Accelerator. Currently, Xeltis is conducting ongoing clinical trials to advance its restorative cardiovascular solutions.

kfzteile24 GmbH is a German retailer specializing in automotive spare parts and accessories, operating primarily online through its platforms www.kfzteile24.de and www.autoteile24.de. Founded in 2001 and headquartered in Berlin, the company has established itself as one of the largest online auto parts retailers in Germany, achieving significant sales growth over the years. In addition to its online presence, kfzteile24 operates three physical retail stores that are affiliated with repair shops, enhancing its service offerings. The company provides a wide range of automotive products, including exhaust systems, batteries, and braking systems, and features a vehicle selection tool that facilitates the quick identification of required parts. Customers also benefit from in-house support from automotive experts who assist in finding suitable replacement parts at competitive prices.

Mongstad Group’s vision is to be a leading Norwegian port landlord and developer of supply base assets, and their mission is to provide efficient infrastructure and properties that add value for their customers in the offshore logistics supply chain. Mongstad Group is the main landlord to the leading supply base in the Northern North Sea area, which was established in 1984. Mongstad Supply Base serves around 20 producing platforms, including the Troll and Oseberg fields. With more than 1,000,000 m2 of land, 60,000 m2 of buildings and 800 meters of quay, the supply base handles approximately 3,000 ship arrivals per year and more than 1,000,000 tons over quay, making it one of the most active supply bases in Norway.

Kuros Biosciences AG is a Swiss biopharmaceutical company dedicated to developing innovative products for tissue repair and regeneration. Founded in 2000 as a spin-off from the Eidgenössische Technische Hochschule Zürich, Kuros has created a diverse pipeline leveraging proprietary technologies. The company specializes in biopharmaceutical products aimed at treating chronic diseases, focusing on sealants and orthobiologics. Its sealant product, Neuroseal, is under review for CE marking in the EU, while its orthobiologics offerings include MagnetOs Granules and MagnetOs Putty, approved for orthopedic and dental use in both the EU and the US. Kuros also has advanced clinical programs, with products like KUR-111 and KUR-113 having completed Phase II trials for bone fractures. Collaborations, such as with Checkmate Pharmaceuticals, further enhance its oncology treatment development. With its operational base in Schlieren, Switzerland, Kuros is transitioning to a commercial stage, aiming for broader market reach in key therapeutic areas.

HusCompagniet is a market leader in Denmark and rapidly growing positions in Germany and Sweden. HusCompagniet builds on a strong brand and business model, delivering high quality single-family houses with great value for money. By taking large market shares in recent years, the Company is now three times larger than the nearest competitor on the Danish market. In 2014, HusCompagniet delivered 1,010 houses to customers in Denmark, Sweden and Germany. The revenue has grown from DKK 1.2 billion in 2011 to DKK 1.8 billion in 2014. The company employs 230 people. HusCompagniet have been awarded House Builder of the Year in Denmark the last three years.

Xeltis is a clinical-stage medical device company focused on transforming cardiovascular treatment through innovative restorative technologies. The company has developed advanced polymer-based devices, including bioabsorbable heart valves and implantable small diameter blood vessels, intended for hemodialysis vascular access and coronary artery bypass graft surgery. These devices leverage proprietary technology to facilitate endogenous tissue restoration, allowing the body to naturally regenerate the complex structures being replaced. Xeltis emerged from the merger of two university spin-offs from the Netherlands and Switzerland and operates in both the Netherlands and the USA. The company is backed by several venture capital firms and has secured significant funding from the European Investment Bank and the European Innovation Council Accelerator. Currently, Xeltis is conducting ongoing clinical trials to advance its restorative cardiovascular solutions.

Musti ja Mirri Group (MMG) is the leading pet specialty retailer in Nordic countries. MMG’s product assortment comprises a complete range of pet supplies and accessories related to the pets’ well-being as well as pet foods. The chain has 127 stores in Finland and Sweden. MMG generated turnover of EUR 81 million in the year to September 2014 with 500 employees.

Curetis AG, founded in 2015 and based in Holzgerlingen, Germany, develops molecular diagnostics solutions aimed at detecting infectious diseases, pathogens, and antibiotic resistance markers. The company specializes in multiparameter testing, enabling the simultaneous analysis of various analytes in a single run. Its primary focus is on providing comprehensive panels for detecting severe bacterial infections, offering rapid diagnostic solutions that help physicians obtain early and actionable insights in managing infectious diseases and antimicrobial resistance. Curetis operates as a subsidiary of OpGen, Inc. and is positioned to expand its diagnostic capabilities into other clinical applications beyond infectious diseases in the future.

Hector Rail is an independent provider of line haul traction and related services within the European rail transport market. Since its acquisition by EQT Infrastructure II in 2014, the company has focused on delivering modern, environmentally-friendly rail solutions that prioritize high quality and performance. Hector Rail serves a diverse clientele, including industrial shippers, forwarders, intermodal operators, and traditional railway companies, primarily in Scandinavia. The company supports key industries such as timber, steel, and lime, contributing to the overall growth of the European economy through efficient transportation and freight services.

Hector Rail is an independent provider of line haul traction and related services within the European rail transport market. Since its acquisition by EQT Infrastructure II in 2014, the company has focused on delivering modern, environmentally-friendly rail solutions that prioritize high quality and performance. Hector Rail serves a diverse clientele, including industrial shippers, forwarders, intermodal operators, and traditional railway companies, primarily in Scandinavia. The company supports key industries such as timber, steel, and lime, contributing to the overall growth of the European economy through efficient transportation and freight services.